Furukawa, T. A., Kawakami, N., Saitoh, M., Ono, Y., Nakane, Y., Nakamura, Y., Tachimori, H., Iwata, N., Uda, H., Nakane, H., Watanabe, M., Naganuma, Y., Hata, Y., Kobayashi, M. & Miyake, Y. (in press) The performance of the Japanese version of the K6 and K10 in the World Mental Health Survey Japan. International Journal of Methods in Psychiatric Research.

Furukawa, T. A., Akechi, T., Azuma, H., Okuyama, T. & Higuchi, T. (2007) Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression. Journal of Clinical Psychopharmacology, 27, 531-534.

Furukawa, T. A., Kessler, R., Andrews, G. & Slade, T. (2003). The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being. Psychological Medicine 33, 357-362.

Cipriani, A., Furukawa, T. A., Geddes, J., Malvini, L., Signoretti, A., Churchill, R., McGuire, H., Nakagawa, A. & Barbui, C. (in press) Does randomised evidence support a first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis. Journal of Clinical Psychiatry.

Akechi, T., Okuyama, T., Onishi, J., Morita, T. & Furukawa, T. A. (in press) Psychotherapy for depression among incurable cancer patients. Cochrane Database of Systematic Reviews.

Watanabe, N., Omori, I. M., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. & Furukawa, T. A. (in press) Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: Systematic review and meta-analysis. Journal of Clinical Psychiatry.

Nakagawa, A., Watanabe, N., Omori, I. M., Furukawa, T. A., Barbui, C., Cipriani, A., McGuire, H. & Churchill, R. (in press) Efficacy and acceptability of milnacipran in the treatment of major depression in comparison with other antidepressants: a systematic review and meta-analysis. CNS Drugs.

Furukawa, T. A., Watanabe, N., Omori, I. M. & Churchill, R. (in press) Can pill placebo augment cognitive-behavior therapy for panic disorder? BMC Psychiatry.

Omori, I., Watanabe, N., Nakagawa, A., Akechi, T., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. & Furukawa, T. A. (in press) Efficacy, tolerability and side effect profie of fluvoxamine for major depression: meta-analysis. Journal of Psychopharmacology.

Furukawa, T. A., Watanabe, N. & Omori, I. M. (in press) What (no) differences in response to three classes of psychotropics can teach us about distinctions between GAD and MDD. In Diagnostic Issues in Depression and Generalized Anxiety Disorder: Refining the Research Agenda for DSM-V. (eds D. Goldberg, K. S. Kendler, P. Sirovatka, et al). Arlington, VA: American Psychiatric Association.

Barbui, C., Furukawa, T. A. & Cipriani, A. (2008) Effectiveness of serotonin reuptake inhibitors. Canadian Medical Association Journal, 178, 1185-1186.

Barbui, C., Furukawa, T. A. & Cipriani, A. (2008) Effectiveness of paroxetine in the acute phase treatment of adults with major depression: a systematic re-examination of published and unpublished randomised data. Canadian Medical Association Journal, 178, 296-305.

Furukawa, T. A., Cipriani, A., Barbui, C. & Geddes, J. R. (2007) Long-term treatment of depression with antidepressants: A systematic narrative review. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 52, 545-552.

Geddes, J. R., Furukawa, T. A., Cipriani, A. & Barbui, C. (2007) Depressive disorder needs an evidence base commensurate with its public health importance. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 52, 543-544.

Cipriani, A., Geddes, J. R., Furukawa, T. A. & Barbui, C. (2007) Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 52, 553-562.

Martin, J. L., Sainz-Pardo, M., Furukawa, T. A., Martin-Sanchez, E., Seoane, T. & Galan, C. (2007) Review: Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. Journal of Psychopharmacology, 21, 774-782.

Watanabe, N., Hunot, V., Omori, I. M., Churchill, R. & Furukawa, T. A. (2007) Psychotherapy for depression among children and adolescents: a systematic review. Acta Psychiatrica Scandinavica, 116, 84-95.

Cipriani, A., Malvini, L., Furukawa, T. A. & Barbui, C. (2007) Relationship Between Quality of Reports of Antidepressant Randomized Controlled Trials and Treatment Estimates: Systematic Review, Meta-Analysis, and Meta-Regression Analysis. Journal of Clinical Psychopharmacology, 27, 352-356.

Watanabe, N., Churchill, R. & Furukawa, T. A. (2007) Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review. BMC Psychiatry, 7, 18.

Furukawa, T., Watanabe, N. & Churchill, R. (2007) Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database of Systematic Reviews, CD004364.

Cipriani, A., Barbui, C., Brambilla, P., Furukawa, T., Hotopf, M. & Geddes, J. (2006) Are all antidepressants really the same? The case of fluoxetine: a systematic review. Journal of Clinical Psychiatry, 67, 850-864.

Furukawa, T. A., Watanabe, N. & Churchill, R. (2006) Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. British Journal of Psychiatry, 188, 305-312.

Cipriani, A., Brambilla, P., Furukawa, T., Geddes, J., Gregis, M., Hotopf, M., Malvini, L. & Barbui, C. (2005) Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev, 4, CD004185.

Furukawa, T. (2004). Low dosage TCA for depression: What have psychopharmacologists been doing for 50 years? Journal of Affective Disorders 78 Supplement 1, S30.

Inada, T., Nozaki, S., Inagaki, A. & Furukawa, T. A. (2003). Efficacy of diazepam as an anti-anxiety agent: meta-analysis of the double-blind rnadomized controlled trials in Japan. Hum Psychopharmacol Clin Exp 18, 483-487.

Furukawa, T., McGuire, H. & Barbui, C. (2003). Low dosage tricyclic antidepressants for depression (Cochrane review). In The Cochrane Library (Update Software: Oxford.)

Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E. & Goodwin, G. M. (2003). Relapse prevention with antidepressant drug treatment in depressive disorders. Lancet 361, 653-61.
[You can have a look at the editorial comment on this paper here, by logging in (free).]
[You can also have a look at the full paper here, if you are subscribing to the Lancet.]
[This meta-analysis has been abstracted in secondary journals including Evidence-Based Mental Health.]

Furukawa, T. A., Barbui, C. & McGuire, H. (2003). Low dosage tricyclic antidepressant in depression: Author's reply. BMJ 326, 499.
[And "Letters" in paper version here.]